Outlook Therapeutics, Inc. (OTLK) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$47.39M2016: -$53.30M2017: -$38.85M2018: -$30.09M2019: -$34.52M2020: -$35.24M2021: -$53.16M2022: -$66.05M2023: -$58.98M2024: -$75.37M2025: -$62.42M-$62.42M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$62.42M+17.2%
2024-$75.37M-27.8%
2023-$58.98M+10.7%
2022-$66.05M-24.2%
2021-$53.16M-50.9%
2020-$35.24M-2.1%
2019-$34.52M-14.7%
2018-$30.09M+22.5%
2017-$38.85M+27.1%
2016-$53.30M-12.5%
2015-$47.39M